EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Ultradian hydrocortisone replacement alters neuronal processing, emotional ambiguity, affect and fatigue in adrenal insufficiency: The PULSES trial

Georgina Russell iD, Konstantinos Kalafatakis, Claire Durant, Nicola Marchant, Jamini Thakrar, Russell Thirard, Jade King, Jane Bowles, Thomas Upton, Ngoc Jade Thai, Jonathan C W Brooks, Aileen Wilson und 9 weitere

Journal of Internal Medicine · 2024

DOI: 10.1111/joim.13721 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Internal Medicine, 2024. Verfasst von Georgina Russell und 20 weiteren Autor:innen. Beteiligte Einrichtung: Laboratories of Integrative Neuroscience and Endocrinology, Bristol Medical School, University of Bristol, Bristol, UK. Hauptthemen laut MEDLINE: Adrenal Insufficiency, Hydrocortisone. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, University of Oxford, University Hospitals Bristol NHS Foundation Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Primary adrenal insufficiency (PAI) mortality and morbidity remain unacceptably high, possibly arising as glucocorticoid replacement does not replicate natural physiology. A pulsatile subcutaneous pump can closely replicate cortisol's circadian and ultradian rhythm.

Objectives

To assess the effect of pump therapy on quality of life, mood, functional neuroimaging, behavioural/cognitive responses, sleep and metabolism.

Methods

A 6‐week randomised, crossover, double‐blinded and placebo‐controlled feasibility study of usual dose hydrocortisone in PAI administered as either pulsed subcutaneous or standard care in Bristol, United Kingdom (ISRCTN67193733). Participants were stratified by adrenal insufficiency type. All participants who received study drugs are included in the analysis. The primary outcome, the facial expression recognition task (FERT), occurred at week 6.

Results

Between December 2014 and 2017, 22 participants were recruited – 20 completed both arms, and 21 were analysed. The pump was well‐tolerated. No change was seen in the FERT primary outcome; however, there were subjective improvements in fatigue and mood. Additionally, functional magnetic resonance imaging revealed differential neural processing to emotional cues and visual stimulation. Region of interest analysis identified the left amygdala and insula, key glucocorticoid‐sensitive regions involved in emotional ambiguity. FERT post hoc analysis confirmed this response. There were four serious adverse events (AE): three intercurrent illnesses requiring hospitalisation (1/3, 33.3% pump) and a planned procedure (1/1, 100% pump). There was a small number of expected AEs: infusion site bruising/itching (3/5, 60% pump), intercurrent illness requiring extra (3/7, 42% pump) and no extra (4/6, 66% pump) steroid.

Conclusions

These findings support the administration of hormone therapy that mimics physiology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenal InsufficiencyHydrocortisoneHumansFatigueGlucocorticoidsQuality of LifeUltradian RhythmFeasibility Studies

Stichwörter der Autor:innen

fMRIglucocorticoid replacement therapyprimary adrenal insufficiencyultradian

Substanzen

GlucocorticoidsHydrocortisone

Autor:innen und Institutionen

  • Laboratories of Integrative Neuroscience and Endocrinology, Bristol Medical School, University of Bristol, Bristol, UK.
  • University Hospital Bristol and Weston NHS Foundation Trust, Bristol, UK.
  • North Bristol NHS Trust, Bristol, UK.
  • Department of Informatics and Telecommunications, Human-Computer Interaction Laboratory, University of Ioannina, Arta, Greece.
  • Clinical Research and Imaging Centre, University of Bristol, Bristol, UK.
  • Faculty of Medicine and Dentistry (Malta Campus), Queen Mary University of London, Victoria, Malta.

ORCID-Profile: Georgina Russell

Förderung

  • Medical Research Council
  • University of Oxford
  • University Hospitals Bristol NHS Foundation Trust

Zitieren

APA

Russell, G., Kalafatakis, K., Durant, C., Marchant, N., Thakrar, J., Thirard, R., King, J., Bowles, J., Upton, T., Thai, N. J., Brooks, J. C. W., Wilson, A., Phillips, K., Ferguson, S., Grabski, M., Rogers, C. A., Lampros, T., Wilson, S., Harmer, C., …, & Lightman, S. L. (2024). Ultradian hydrocortisone replacement alters neuronal processing, emotional ambiguity, affect and fatigue in adrenal insufficiency: The PULSES trial. Journal of Internal Medicine. https://doi.org/10.1111/joim.13721

Vancouver

Russell G, Kalafatakis K, Durant C, Marchant N, Thakrar J, Thirard R, et al. Ultradian hydrocortisone replacement alters neuronal processing, emotional ambiguity, affect and fatigue in adrenal insufficiency: The PULSES trial. Journal of Internal Medicine. 2024. doi:10.1111/joim.13721

BibTeX
@article{Russell2024,
  author = {Russell, Georgina and Kalafatakis, Konstantinos and Durant, Claire and Marchant, Nicola and Thakrar, Jamini and Thirard, Russell and King, Jade and Bowles, Jane and Upton, Thomas and Thai, Ngoc Jade and Brooks, Jonathan C W and Wilson, Aileen and Phillips, Kirsty and Ferguson, Stuart and Grabski, Meryem and Rogers, Chris A and Lampros, Theodoros and Wilson, Sue and Harmer, Catherine and Munafo, Marcus and Lightman, Stafford L},
  title = {Ultradian hydrocortisone replacement alters neuronal processing, emotional ambiguity, affect and fatigue in adrenal insufficiency: The PULSES trial},
  journal = {Journal of Internal Medicine},
  year = {2024},
  doi = {10.1111/joim.13721}
}
Kostenlos starten →